NCT06880809

Brief Summary

The goal of this clinical trial is to develop and preliminarily test a culturally adapted suicide intervention specifically for black youth. The main question it aims to answer:

  • To evaluate the feasibility and acceptability of the group, as well as the preliminary efficacy of the group for decreasing suicidal thoughts and behaviors and increasing protective factors such as hope, positive ethnic identity, and family and peer support. Participants will be asked to attend 10-week group intervention and complete pre-treatment and post-treatment assessment measures.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
11mo left

Started Jun 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress52%
Jun 2025Jun 2027

First Submitted

Initial submission to the registry

March 12, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 18, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

June 1, 2025

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

April 30, 2026

Status Verified

April 1, 2026

Enrollment Period

1.6 years

First QC Date

March 12, 2025

Last Update Submit

April 27, 2026

Conditions

Keywords

Suicide PreventionBlack YouthCollaborative Assessment & Management of Suicidality (CAMS)Group Intervention

Outcome Measures

Primary Outcomes (8)

  • The Collaborative Assessment & Management of Suicidality - Suicide Status Form (SSF)

    An assessment of suicide risk that consists of six core assessment constructs: psychological pain, stress, agitation, hopelessness, self-hate, and overall risk of suicide; as well as reasons for living and reasons for dying constructs, and wish to live and wish to die constructs.

    From pre-treatment until 3 months post-treatment, approximately 23 weeks.

  • Ethnic Identity Scale (EIS)

    A 17-item scale that assesses the three components of ethnic identity and distinguishes between exploration, resolution, and affirmation. Scores range from 17-68, with higher scores indicating higher levels of affirmation, exploration, and resolution.

    From baseline until 3 months post-treatment, approximately 22 weeks.

  • Living Ladder Scale

    A one-item measure that is prospectively associated with suicidal ideation and suicide attempts by measuring readiness to continue living among individuals thinking of suicide. Scores range from 0-8, with 8 indicating an individual is committed to making changes to make their lives worth living.

    From baseline until 3 months post-treatment, approximately 22 weeks.

  • Brief Suicide Cognitions Scale (B-SCS)

    A 6-item self-report scale that measures the suicidal belief system, including dimensions of unlovability, unbearability, and unsolvability. Scores range from 6-30, with lower scores indicating fewer suicide cognitions.

    From baseline until 3 months post-treatment, approximately 22 weeks.

  • Therapeutic Relationship Working Alliance Inventory, Short Revised (WAI-SR)

    A 12-item scale that reflects Bordin's three-dimensional conceptualization of therapeutic alliance: task, goal, and bond. Scores range from 12-60, with higher scores indicating higher therapeutic alliance.

    From baseline until 3 months post-treatment, approximately 22 weeks.

  • Optimism and Hope Scale (OHS)

    A 14-item scale that measures an individual's level of both optimism, as characterized by a positive outlook on the future, and hope, as characterized by the belief in one's ability to achieve goals and navigate challenges. Scores range from 14-56, with lower scores indicating more hope and optimism.

    From baseline until 3 months post-treatment, approximately 22 weeks.

  • Parent Readiness for Hospital Discharge Scale (RHDS)

    A 23-item scale aimed at providing a discharge readiness assessment before pediatric discharge from care in hospital settings. Scores range from 0-80, with higher scores indicating more readiness.

    From baseline until 3 months post-treatment, approximately 22 weeks.

  • Group Cohesion Scale

    A 12-item self-report scale that measures group cohesion, including dimensions of engagement, conflict, and avoidance. Scores across the subscales range from 0-72; higher scores indicate more of that dimension.

    From baseline until the beginning of post-treatment, approximately 10 weeks.

Study Arms (1)

Treatment Arm

EXPERIMENTAL

Participants will complete a 10-week group and complete pre-treatment and post-treatment assessment measures.

Behavioral: Bridge the Gap (BTG) - Black Youth Group

Interventions

Participants will complete a group intervention, rooted in the Collaborative Assessment \& Management of Suicidality (CAMS) evidence-based model, driven by their own unique identification of suicide drivers.

Treatment Arm

Eligibility Criteria

Age12 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • years old
  • Identify as Black or African American or being of African descent
  • Have current suicidal ideation or suicidal ideation within the last 30 days
  • Have assent from the adolescent participant and consent from an individual's caregiver or guardian to participate.

You may not qualify if:

  • An active psychotic disorder or current psychosis symptoms
  • No history of suicide attempt(s) or suicide ideation in the past 30 days
  • Cognitive deficits or a medical condition diagnosed from a medical provider that precludes full understanding of study materials as assessed through an inability to complete the pre-treatment CAMS SSF \& SSP
  • Caregivers, guardians, and/or the patient refuse to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital Los Angeles

Los Angeles, California, 90027, United States

RECRUITING

MeSH Terms

Conditions

Suicide Prevention

Condition Hierarchy (Ancestors)

SuicideSelf-Injurious BehaviorBehavioral SymptomsBehavior

Study Officials

  • Tia Tyndal, PhD

    Children's Hospital Los Angeles

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tia Tyndal, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator, Licensed Clinical Psychologist

Study Record Dates

First Submitted

March 12, 2025

First Posted

March 18, 2025

Study Start

June 1, 2025

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

April 30, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations